Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/25/2022 | Press release | Distributed by Public on 01/25/2022 02:03
Please select the service you want to use:
Smartlinks | Broadridge Financial Solutions Inc. | News | Local News | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Shareholders | Corporate and Shareholder Meetings | Business Announcement | Proxy Filings | Financial Services | Investment Services | Public Companies | Financial Information Providers | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Börse Frankfurt | Bolsa de Valores de São Paulo (B3) | Börse Berlin | Börse Stuttgart | NYSE American | NYSE ARCA Equities | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | Investors Exchange (IEX) | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact